Wed, February 28, 2024

Jonathan Block Maintained (ARQT) at Hold with Increased Target to $11 on, Feb 28th, 2024

Jonathan Block of Goldman Sachs, Maintained "Arcutis Biotherapeutics, Inc." (ARQT) at Hold with Increased Target from $6 to $11 on, Feb 28th, 2024.

Jonathan has made no other calls on ARQT in the last 4 months.



There are 2 other peers that have a rating on ARQT. Out of the 2 peers that are also analyzing ARQT, 1 agrees with Jonathan's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Sean Kim of "JonesTrading" Downgraded from Strong Buy to Hold on, Wednesday, November 8th, 2023


This is the rating of the analyst that currently disagrees with Jonathan


  • Nigel Dally of "Morgan Stanley" Maintained at Buy with Decreased Target to $10 on, Monday, November 13th, 2023